Brief: Faron Pharmaceuticals Says MHRA Awarded Bexmarilimab An Innovation Passport
Dec 2 (Reuters) - Faron Pharmaceuticals Oy FARN.L :
* FARON PHARMACEUTICALS OY - MHRA HAS AWARDED BEXMARILIMAB
AN
INNOVATION PASSPORT
* FARON PHARMACEUTICALS OY - UK SITES TO JOIN BEXMAB STUDY
IMINENTLY
Source text: ID:nRSB3747Oa
Further company coverage: FARN.L
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Faron Pharmaceuticals Oy
See all newsFaron Pharmaceuticals: Faron to Report Final Melanoma Survival Data from the MATINS Study at ESMO 2026
Faron Pharmaceuticals: Composition of Faron Pharmaceutical’s Shareholders’ Nomination Board
Convertible bond amortization payment deferred by mutual agreement with HCM
Issuance of warrants
HOLDING(S) IN COMPANY